Tyler Robert Nelson - 09 Jun 2022 Form 4 Insider Report for Vivakor, Inc. (VIVK)

Reporting relationship: Chief Financial Officer
Issuer ticker: VIVK
Reported as of: 09 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jun 2022, 20:18:29 UTC
Prior SEC filing: 02 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Tyler Nelson

Key filing fact

Tyler Robert Nelson filed Form 4 for Vivakor, Inc. (VIVK) on 13 Jun 2022.

Key facts

This page summarizes Tyler Robert Nelson's Form 4 filing for Vivakor, Inc. (VIVK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Jun 2022, 20:18.

Change

Previous filing in this sequence was filed on 02 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIVK transaction Derivative

Stock Option to Purchase Common Stock

Award

Transaction value: $0
Shares: +917,825
Change %
Price: $0.000000
Shares after: 917,825
Date: 09 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 917,825
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Tyler Nelson. Pursuant to the Agreement, the Company granted Mr. Nelson a stock option to acquire 917,825 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 360,145 of the shares vesting immediately, 219,312 of the shares vesting three (3) months after issuance, and the remaining 338,368 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (48,338 for 6 quarters and 48,340 in the last quarter), with an exercise price equal to 100% of the fair market value on the date grant, and which expires ten (10) years after the date of grant.